BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2536266)

  • 21. [A case of advanced breast cancer responding to low-dose 5'-DFUR].
    Koh J; Murayama Y; Sano M; Katai H; Maeda K; Sakai S; Yamamoto O; Hashimoto M; Hosoda Y
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1063-6. PubMed ID: 1385689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A case of advanced breast cancer with multiple lung metastases responding well to postoperative combined administration of doxifluridine (5'-DFUR) and tamoxifen].
    Tohma H; Noshiro H; Hachiya Y; Akashi Y; Miyoshi A
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1267-9. PubMed ID: 8031170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A 5'-DFUR + CPA + THP therapy that was effective for paclitaxel-refractory pulmonary metastasis of breast cancer--a case report].
    Kitahara S; Ogata H; Katagiri T; Nonaka K; Shiba T
    Gan To Kagaku Ryoho; 2002 Jan; 29(1):111-4. PubMed ID: 11816465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of breast cancer with multiple organ metastases in which single low dose administration of 5'-DFUR proved effective].
    Kataoka T; Okamoto T; Gotoh T; Sadamoto S; Nishiki M; Dohi K
    Gan To Kagaku Ryoho; 1993 Feb; 20(2):299-302. PubMed ID: 8434970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
    Okamoto Y; Tominaga T; Okuyama N; Sawada T; Kou Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):661-7. PubMed ID: 12795098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Successful treatment of advanced recurent breast cancer using DMpC therapy as maintenance therapy].
    Miyamoto H; Yoshida S; Imatomi M; Saitoh T; Nakata A
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):427-9. PubMed ID: 11915733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two cases of effective weekly paclitaxel administration for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kim Y; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1905-8. PubMed ID: 11729485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment].
    Yamada Y; Miyagawa T; Toyoda H; Uesato K; Asanuma F
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1335-40. PubMed ID: 9279356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Successful treatment of disseminated breast cancer with combination therapy of 5'-deoxy-5'-fluorouridine (5'-DFUR), medroxyprogesterone acetate (MPA) and cyclophosphamide (CPA)].
    Takatsuka Y; Katoh T; Tsumura I; Kobayakawa K; Kawahara T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):107-10. PubMed ID: 1530905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case report of advanced breast cancer effectively treated by chemo-endocrine therapy with diethylstilbestrol diphosphate and cyclophosphamide].
    Hareyama M; Saito A; Oouchi A; Morita K
    Gan To Kagaku Ryoho; 1989 Jul; 16(7):2453-6. PubMed ID: 2751322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan.
    Kimura M; Tominaga T; Takatsuka Y; Toi M; Abe R; Koyama H; Takashima S; Nomura Y; Miura S; Kimijima I; Tashiro H; Ohashi Y;
    Breast Cancer; 2010 Jul; 17(3):190-8. PubMed ID: 19575284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Two cases of advanced breast cancer responding to oral chemoendocrine therapy with 5'-deoxy-5-fluorouridine, medroxyprogesterone acetate and cyclophosphamide (DMpC)].
    Kihara M; Kontani K; Yamauchi A; Yokomise H
    Gan To Kagaku Ryoho; 2005 May; 32(5):683-6. PubMed ID: 15918573
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of advanced gastric cancer with direct invasion of the transverse colon responding to paclitaxel/5'-DFUR combined therapy].
    Fukuda Y; Fujio N; Ihara T; Takatori H; Tsukazaki T; Koyama I; Tsukazaki Y; Osugi H
    Gan To Kagaku Ryoho; 2005 Nov; 32(12):1945-8. PubMed ID: 16282732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case of advanced male breast cancer successfully treated by 5-fluorouracil, epirubicin and cyclophosphamide chemotherapy combined with tamoxifen.
    Tanaka Y; Ohmori Y; Toki T; Okazaki Y; Ogoshi S; Ogawa Y
    Nihon Geka Hokan; 1995 Jan; 64(1):15-22. PubMed ID: 8534185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of stage IV breast cancer with large cancer ulcer responding to combination therapy of capecitabine and medroxyprogesterone acetate and cyclophosphamide].
    Konishi K; Hasegawa N; Kaneko H; Iimura Y; Shoji Y; Kawabata M
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1525-8. PubMed ID: 19755825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.
    Yamashita T; Yamashita H; Itoh Y; Karamatsu S; Itoh K; Hara Y; Ando Y; Sugiura H; Kuzushima T; Toyama T; Iwata H; Kobayashi S; Iwase H
    Breast Cancer; 2006; 13(4):334-9. PubMed ID: 17146158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
    Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
    Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
    Rodenhuis S; Richel DJ; van der Wall E; Schornagel JH; Baars JW; Koning CC; Peterse JL; Borger JH; Nooijen WJ; Bakx R; Dalesio O; Rutgers E
    Lancet; 1998 Aug; 352(9127):515-21. PubMed ID: 9716055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Advanced breast cancer with multiple bone metastases successfully treated with combined chemoendocrine-therapy of CEF (cyclophosphamide, epirubicin, 5-fluorouracil) and 5'-DFUR (5'-deoxy-5-fluorouridine) + MPA (medroxyprogesterone acetate)--a case report].
    Fukuda Y; Hirao S; Koyama I; Takatori H; Terakura M; Mayumi K; Tsukazaki Y; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Feb; 28(2):217-20. PubMed ID: 11242649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.